Ivy Natal
Unlocking human fertility
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2C
- Website
- ivynatal.com
- Total Funding
- $250K
- Last Round
- $250K SeedApr 2020
- Rounds
- 1
About
Ivy Natal is a San Francisco-based VC-backed biotech company developing in vitro gametogenesis (IVG) technology to enable women who cannot produce eggs — due to surgery, chemotherapy, age, or genetic conditions — to have genetic children. The process begins with a simple skin biopsy and directly reprograms skin cells into healthy egg cells, bypassing traditional IVF limitations. Long term, the platform aims to extend reproductive choice to same-sex couples and anyone facing infertility.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Apr 2020
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...